This topic contains a solution. Click here to go to the answer

Author Question: When was positive end expiratory pressure (PEEP) first introduced to treat patients with acute ... (Read 36 times)

darbym82

  • Hero Member
  • *****
  • Posts: 570
When was positive end expiratory pressure (PEEP) first introduced to treat patients with acute respiratory distress syndrome?
 
  a. 1935
  b. 1946
  c. 1958
  d. 1967

Question 2

When was the first Venti-mask introduced that allows the precise delivery of 24, 28, 35, and 40 O2?
 
  a. 1945
  b. 1954
  c. 1960
  d. 1972



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

javimendoza7

  • Sr. Member
  • ****
  • Posts: 293
Answer to Question 1

ANS: D
Positive end expiratory pressure (PEEP) was introduced for use in patients with ARDS in 1967.

Answer to Question 2

ANS: C
The Campbell Venti-mask, which allowed the administration of 24, 28, 35, or 40 O2, was introduced in 1960.




darbym82

  • Member
  • Posts: 570
Reply 2 on: Jul 16, 2018
Great answer, keep it coming :)


patma1981

  • Member
  • Posts: 292
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

When blood is deoxygenated and flowing back to the heart through the veins, it is dark reddish-blue in color. Blood in the arteries that is oxygenated and flowing out to the body is bright red. Whereas arterial blood comes out in spurts, venous blood flows.

Did you know?

There are 20 feet of blood vessels in each square inch of human skin.

Did you know?

The average older adult in the United States takes five prescription drugs per day. Half of these drugs contain a sedative. Alcohol should therefore be avoided by most senior citizens because of the dangerous interactions between alcohol and sedatives.

Did you know?

Drugs are in development that may cure asthma and hay fever once and for all. They target leukotrienes, which are known to cause tightening of the air passages in the lungs and increase mucus productions in nasal passages.

For a complete list of videos, visit our video library